SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Buss, N.E.
Right arrow Articles by George, C.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buss, N.E.
Right arrow Articles by George, C.F.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*TRANS-RETINOIC ACID
*VITAMIN A
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Teratogenic Metabolites of Vitamin A in Women Following Supplements and Liver

N.E. Buss

Clinical Pharmacology Group, University of Southampton, Biomedical Sciences Building, Bassett Crescent East, Southampton, SO9 3TU, UK

E.A. Tembe

Clinical Pharmacology Group, University of Southampton, Biomedical Sciences Building, Bassett Crescent East, Southampton, SO9 3TU, UK

B.D. Prendergast

Clinical Pharmacology Group, University of Southampton, Biomedical Sciences Building, Bassett Crescent East, Southampton, SO9 3TU, UK

A.G. Renwick

Clinical Pharmacology Group, University of Southampton, Biomedical Sciences Building, Bassett Crescent East, Southampton, SO9 3TU, UK

C.F. George

Clinical Pharmacology Group, University of Southampton, Biomedical Sciences Building, Bassett Crescent East, Southampton, SO9 3TU, UK

1 Ten healthy female volunteers were given 5 doses of retinol as the palmitate; 50 and 150 mg retinol as an oral supplement, 50 and 150 mg as fried calf liver (50 and 150 g) and 3, 9 or 30 mg by intra-muscular injection.

2 Plasma concentrations of retinyl palmitate were higher after 50 mg retinol given as an oral supplement compared with 50 mg as liver; there was no significant difference between the 150 mg doses. Plasma concentrations of retinol showed only small increases.

3 The peak plasma concentrations (Cmax) of all-trans-retinoic acid, the principal teratogenic metabolite of retinol, and the area under the concentration-time curve (AUC) were up to 20-times higher after supplements compared to the same dose as liver. Plasma concentrations of all-trans-4-oxo-retinoic acid, 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid showed smaller differences between supplements and liver.

4 Intra-muscular administration of 30 mg retinol gave retinyl palmitate concentrations similar to those found after the oral doses but did not increase circulating concentrations of the acid metabolites.

5 Based on the formation of all-trans-retinoic acid, liver and supplements are not of equivalent teratogenic potential. Advice to pregnant women on the consumption of liver based on the reported teratogenicity of vitamin A supplements should be reconsidered.

Human & Experimental Toxicology, Vol. 13, No. 1, 33-43 (1994)
DOI: 10.1177/096032719401300106


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
K. L Penniston and S. A Tanumihardjo
The acute and chronic toxic effects of vitamin A
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 191 - 201.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. G. Renwick
Toxicology of Micronutrients: Adverse Effects and Uncertainty
J. Nutr., February 1, 2006; 136(2): 493S - 501S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. Arnhold, H. Nau, S. Meyer, H. J. Rothkoetter, and A. D. Lampen
Porcine Intestinal Metabolism of Excess Vitamin A Differs Following Vitamin A Supplementation and Liver Consumption
J. Nutr., February 1, 2002; 132(2): 197 - 203.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. van Vliet, E. Boelsma, A. J. de Vries, and H. van den Berg
Retinoic Acid Metabolites in Plasma Are Higher after Intake of Liver Paste Compared with a Vitamin A Supplement in Women
J. Nutr., December 1, 2001; 131(12): 3197 - 3203.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
V. Azais-Braesco and G. Pascal
Vitamin A in pregnancy: requirements and safety limits
Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1325S - 1333.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
P. Borel, P. Grolier, N. Mekki, Y. Boirie, Y. Rochette, B. Le Roy, M. C. Alexandre-Gouabau, D. Lairon, and V. Azais-Braesco
Low and high responders to pharmacological doses of ß-carotene: proportion in the population, mechanisms involved and consequences on ß-carotene metabolism
J. Lipid Res., November 1, 1998; 39(11): 2250 - 2260.
[Abstract] [Full Text]



Advertisement